Poor health and functioning in patients with axial spondyloarthritis during the COVID-19 pandemic and lockdown: REUMAVID study (phase 1).
Diego BenaventMarco Garrido-CumbreraChamaida Plasencia-RodríguezHelena Marzo-OrtegaLaura ChristenJosé Correa-FernándezPedro Plazuelo-RamosDale WebbVictoria Navarro-CompánPublished in: Therapeutic advances in musculoskeletal disease (2022)
During the first wave of the COVID-19 pandemic, one in four axSpA patients reported poor health and functioning, while the self-perceived health status of almost half of these patients worsened. Nonsmoking, physical activity and being employed were associated with better outcomes.